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I was alerted to the measurement of a serum calcium concentration of 4´45 mmol/L in a patient in the A&E department. Total protein, albumin, phosphate, urea and electrolyte concentrations were within normal reference ranges.
The sample (from an adult) had arrived in a paediatric heparin tube and there was very little sample left.
A repeat sample was hastily arranged, which showed a normal calcium concentration and other parameters, with little change apart from an increased urea concentration, from 4´1 to 5´2 mmol/L. Discussion with the clinician who took the blood revealed that the blood was the product of an attempt at arterial sampling for blood gases using a concord Laboratories Pulsator 3M arterial sampling syringe (Concord Laboratories, Hythe, Kent, England). The doctor informed me that he had noticed an air bubble in the sample and decided to send the blood for other chemistry tests instead. Having been commended for not processing the blood gas sample, further enquiry revealed that he had failed to expel the air and liquid anticoagulant from the syringe prior to sampling. This prompted me to investigate the contents of the liquid in the syringe which claims to be`balanced for Na + , K + , Cl 2 , & Ca ++ electrolytes'.
Following suitable dilutions and analysis we found that the 0´5 mL of liquid contained: The authors also say that the HbA 1c may become less sensitive to change in mean blood glucose as the latter rises and support this by showing that the glycation index (ratio of % HbA 1c to 28-day running mean blood glucose) was inversely related to the running mean blood glucose to a degree that reached statistical signi®cance in six out of the 10 patients studied. What is not clear is the chronological order of the observations, i.e. whether the changes in blood glucose represented a progressive improvement or deterioration of glucose control or whether the changes were random. Their ®g. 2 shows that some patients had marked changes in running mean glucose during the study (e.g. patient 1, whose HbA 1c nevertheless remained fairly constant), while others showed very little change in mean glucose (e.g. patient 8, who despite a stable mean glucose had one anomalously low HbA 1c value), and at least two patients (cases 3 and 5) seemed each to have two separate populations of mean glucose values during the study. A progressive improvement might indicate a change in therapy, but this was not mentioned. If the change were progressive and the HbA 1c lagged behind the 28-day mean glucose change, then a trend towards lower mean glucose would result in a higher glycation index and a trend towards higher glucose would produce a lower glycation index, explaining the ®ndings. Although this may not be the correct explanation, and the authors say that`all results were con®rmed with rolling mean glucose values calculated for up to 70 days prior to blood sampling for HbA 1c assay', it still needs to be given serious consideration, as a basic assumption in the paper is that a 28-day running mean blood glucose, calculated from one preand one post-prandial blood glucose measurement per day, is a reliable indicator of glycaemic status and, on the basis of evidence from other studies, might be expected to have good correlation with HbA 1c levels. Having based their study on this, the authors then proceed to disprove it, ®nding r=0´23 for their total population of 10 patients, with only one individual patient showing signi®cant correlation between HbA 1c and 28-day mean blood glucose. In a study of 401 patients undergoing oral glucose tolerance testing, we found highly signi®cant correlation (i.e. r within the range 0´75 to 0´78; P< 0´001) between HbA 1c and both fasting plasma glucose and 2-h plasma glucose. 4 Furthermore, it seems paradoxical that increased duration of diabetes increases the glycation index if increased blood glucose decreases it, especially as the natural tendency is for glycaemic control to deteriorate with increased duration of diabetes in the absence of more stringent therapeutic control. Some of the previous studies showing increasing HbA 1c with increasing duration of diabetes have been conducted on children whose condition has been relatively short-lived, and one follow-up study indicated that the increases in HbA 1c and insulin requirement closely corresponded to the loss of endogenous insulin secretion. 5 Examining the details for the patients in Tables 1 and 2 of Hudson and colleagues' paper suggests that the subjects with the longest duration of diabetes have blood glucose levels in the upper half of the range. However, it is doubtful whether data from only 10 patients are suf®cient to warrant reliable conclusions, especially as glucose levels in diabetic subjects treated with insulin can uctuate widely within 24 h, and two-point measurements during the period can give only a very approximate guide to the mean value and the area under the curve.
We feel, therefore, that the case for different glycation rates in different people is not convincingly proven by this study. The observations might just as easily result from different patterns of glucose control in different individuals, which might not be detected by twice-daily glucose measurement. For example, a wide glucose peak is likely to have a greater effect on HbA 1c than a narrow peak of the same height, i.e. it is the length of time that a person's glucose remains raised that is important, rather than the amplitude of the swing.
Despite these shortcomings, this study draws attention to some interesting relationships and casts doubt on our conventional assumptions, and the authors are to be congratulated for attempting to elucidate some aspects of a very complex situation. 
Author's reply
We did not present our data arranged chronologically, in the interests of brevity. In ®g. 1 we show two contrasting times series from our study. The HbA 1c of patient 1 was relatively insensitive to a range of mean blood glucose values (8´2 to 13´0 mmol/L), whereas patient 7, the only patient to show any obvious trend, showed good`tracking' between the two measures for mean blood glucose values between 10´2 and 12´8 mmol/L. Other patients demonstrated random patterns of peaks and troughs of mean blood glucose and HbA 1c . Small adjustments were made to some patients' insulin doses during the course of the study, but no radical changes were made (such as changing to a different insulin preparation).
To add more detail to our statement that results were con®rmed with rolling mean glucose calculated for up to 70 days', we reproduce our own ®g. 3, this time using the 70-day mean blood glucose to calculate the glycation index (see ®g. 2). Despite the small number of observations for each patient (three or four), there are still highly signi®cant differences between individuals by analysis of variance (F 9,22 =4´8, P=0´0013).
Previous cross-sectional studies 1,2 have shown good correlation between HbA 1c and previous mean blood glucose. Both of these studies showed, as did our study, that any particular HbA 1c value may be associated with a wide range of mean blood glucose values. The study by Service et al. 1 also illustrates the problems in extrapolating the results of cross-sectional studies to individual patients. In a longitudinal series of 16 patients, they demonstrated a poor correlation between mean blood glucose and HbA 1c . This series of patients provides additional evidence of a decline in glycation index with increasing mean blood glucose. When the data are re-plotted as glycation index against mean blood glucose, nine of the 16 patients show convincing negative linear trends. Although there are too few data points for each patient for regression analysis, when pooled the data show a highly signi®cant fall in glycation index with increasing mean blood glucose (regression parameter 2 0´11, standard error 0´011, P< 0´0001). In addition, as we found in our patients, signi®cant differences in glycation index between individual patients can be demonstrated by analysis of variance (F 15,32 =3´09, P=0´0035).
In these previous studies, blood samples were collected before and after the main meals and at bedtime either once monthly or once quarterly. It may be argued that in some respects our sampling regime was rather more rigorous.
Apart from the bedtime sample, collections were made on three consecutive days instead of on the same day, but they were repeated daily for 3 months. Our patients collected their blood samples 2 h postprandially, in comparison to 90 min in these previous studies. This period of 2 h is well within the broad post-prandial blood glucose peak observed in type 1 diabetic patients; 1 however, the comment that the width of glucose peaks in individual patients may be affecting HbA 1c values is very well made. This could go some way to explaining our observed differences between patients, although it may be only one of a number of possible factors. For example, one variable which was not included in our study was inter-individual variation in redcell survival times.
Drs Wiener and Roberts suggest that it is paradoxical that the glycation index should rise with increasing duration of diabetes, as the natural tendency is for glycaemic control to deteriorate. Although we do not have an explanation for the ®nding, we do not feel the two are incompatible. As we suggested, one possible explanation is that age-related increased oxidative stress may perhaps lead to an increased susceptibility to non-enzymatic glycation.
In summary, we propose that a non-linear relationship between HbA 1c and previous mean blood glucose may, in part, explain the observed inter-individual differences in haemoglobin glycation. Our data suggest that in some patients (for example, our patient 7) the HbA 1c response to mean blood glucose may be in a linear portion of the curve, and that in some patients (for example our patient 1) haemoglobin may be approaching saturation with respect to glycation. The ®nal proof of this proposal would require longitudinal series of observations in patients whose mean blood glucose values covered a wider range of values, particularly at lower levels, than those in our study, and also more frequent blood sampling throughout the day.
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